Earnings Call · Q3 FY2021·2021-11-05

Q3 21EPS -18.26%·Rev n/aQ2 21EPS +10.24%·Rev n/aQ1 21EPS +14.98%·Rev n/aQ4 20EPS -97.14%·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel

David Meline — Chief Financial Officer

Paul Burton — Chief Medical Officer

Stephen Hoge — President

−17.9%1d on move date−18.4% vs SPY3d−29.3%5d−33.8%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access